CompletedNot Applicable

Whey Permeate Study

Malawi2,259 participantsStarted 2013-02

Plain-language summary

This is a prospective, randomized, double-blinded, controlled clinical effectiveness trial of two supplementary foods in the treatment of MAM. Specific Aim 1: Test the effectiveness of two supplementary foods, whey RUSF and soy RUSF, in the treatment of MAM in 6-59 month old children in a 12-week home-based supplementary feeding program. Hypothesis: The proportion of children who recover receiving either soy or whey RUSF will differ by no more than three percent.

Who can participate

Age range6 Months – 59 Months

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Children with MAM defined as mid-upper-arm circumference, MUAC, ≤ 12.5 cm and \> 11.5 cm without bipedal edema. Exclusion Criteria: * Children simultaneously involved in another research trial or supplemental feeding program * Children with developmentally delayed * Children with a chronic debilitating illness such as cerebral palsy (not including HIV or TB) * Children with a history of peanut or milk allergy * Children will also be excluded if they had received therapy for acute malnutrition within one month prior to presentation.

What they're measuring

Recovery From Moderate Acute Malnutrition (MAM)

Timeframe: 3 months

Trial details

NCT IDNCT01790048

SponsorWashington University School of Medicine

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2015-03

Results submitted2018-07-31

View on ClinicalTrials.gov More Malnutrition trials